• Home
  • Meetings
  • 2018 Minority and MSI Faculty Scholar in Cancer Research Awards

​​​2018 Minority and Minority-serving Institution Faculty Scholar in Cancer Research Awards

Anchang_MMSIF_headshots_150x190_1.jpgBenedict  Anchang, PhD
Stanford University
Abstract 2275: Individualized drug combination based on single-cell drug perturbations
Session PO.BSB01.05 - New Software for Data Analysis
April 16, 2018, 1 - 5 p.m.; Section 13, Poster 2

Caban-Martinez_MMSIF_headshots_150x190_1.jpgAlberto J. Caban-Martinez, PhD
Assistant Professor, Public Health Sciences
University of Miami, Miller School of Medicine
Abstract 4249: Disparities in cancer screening between Latino and non-Latino firefighters: Evidence from the Sylvester Firefighter Cancer Initiative
Session PO.EP01.06 - Cancer in Minority Populations, Health Disparities, and Survivorship Research
April 17, 2018, 1 - 5 p.m.; Section 11, Poster 20

Chew_MMSIF_headshots_150x190_1.jpgSue Anne  Chew, PhD
Assistant Professor, Dept. of Health and Biomedical Sciences
University of Texas Rio Grande Valley
Abstract 3719: Fabrication of chemotherapy drug temozolomide-loaded poly(lactic-co-glycolic acid) microparticles by electrospraying for the treatment of glioma
Session PO.CH01.03 - Drug Delivery
April 17, 2018, 8 a.m. - noon; Section 30, Poster 19

Das_MMSIF_headshots_150x190_1.jpgJayanta K. Das, PhD
Research Assistant Professor, Dept. of Environmental and Occupational Health
Florida International University
Abstract 1128: Exosomal ID3 is pro-metastatic through guiding NRF1-induced breast cancer stem cells across the blood-brain-barrier
Session PO.TB02.02 - Regulation of Stemness in Cancer
April 16, 2018, 8 a.m. - noon; Section 5, Poster 15

Davis_MMSIF_headshots_150x190_1.jpgClaudia M. Davis, PhD
Associate Professor and Faculty Fellow
California State University, San Bernardino
Abstract 606A: Biological predictors and the impact of cancer among African American women
Session PO.CL11.01 - Clinical Risk Factors and Outcomes in Solid Tumors / Survivorship Research
April 15, 2018, 1 - 5 p.m.; Section 26, Poster 20

Michelle R. Dawson, PhD
Assistant Professor
Brown University
Abstract 1315: Biophysics of polyploidal cancer cells in an aging stroma
Session PO.BSB02.02 - Integrative Cancer Biology 2
April 16, 2018, 8 a.m. - noon; Section 13, Poster 8

De-Angelo_MMSIF_headshots_150x190_1.jpgAlejandra  De Angulo, PhD
Research Fellow, Dept. of Nutritional Sciences
University of Texas at Austin
Abstract 61: Obesity-induced T cell senescence contributes to prostate cancer progression
Session PO.TB06.01 - Dormancy and Aging: The Influential Microenvironment
April 15, 2018, 1 - 5 p.m.; Section 3, Poster 11

Gamero_MMSIF_headshots_150x190_1.jpgAna M. Gamero, PhD
Associate Professor, Dept. of Biochemistry
Temple University
Abstract 3157: p53 inactivation and STAT2 cooperate to enhance migration and metastasis of colon tumor cells
Session PO.TB04.04 - Metastasis, Invasion, and Migration 1
April 17, 2018, 8 a.m. - noon; Section 6, Poster 9

Godoy_MMSIF_headshots_150x190_1.jpgFilipa G. Godoy-Vitorino, PhD
Assistant Professor
Inter American University of Puerto Rico
Abstract 3267: Cervical microbiota and the urinary metabolome in patients with high-risk and low-risk HPV infections
Session PO.PR02.01 - Prevention, Interception, and Early Detection Research
April 17, 2018, 8 a.m. - noon; Section 11, Poster 21

Hernandez_MMSIF_headshots_150x190_1.jpgSonia L. Hernandez, PhD
Research Assistant Professor
The University of Chicago
Abstract 2055: Staphylococcus aureus alpha toxin activates Notch in endothelial cells
Session PO.TB05.02 - Novel Mechanisms Regulating Angiogenesis
April 16, 2018, 1 - 5 p.m.; Section 3, Poster 14

Imbert-Fernandez_MMSIF_headshots_150x190_1.jpgYoannis  Imbert-Fernandez, PhD
Assistant Professor, Dept. of Medicine
University of Louisville
Abstract 2305: Targeting 6-phosphofructo-2-kinase to increase the efficacy of ER and CDK4/6 inhibitors against breast cancer
Session PO.MCB06.01 - CDK and CDK Inhibitors: Mechanism and Therapy
April 16, 2018, 1 - 5 p.m.; Section 14, Poster 7

Levy_MMSIF_headshots_150x190_1.jpgArkene S. Levy, PhD
Associate Professor
Nova Southeastern University
Abstract 4924: Evaluation of the efficacy of curcumin and Y15 in platinum resistant ovarian cancer cells
Session PO.ET05.02 - Pharmacokinetics and Pharmacodynamics
April 17, 2018, 1 - 5 p.m.; Section 41, Poster 20

Medina_MMSIF_headshots_150x190_1.jpgEdward A. Medina, MD
Assistant Professor, Div. of Hematopathology
UT Health Science Center at San Antonio
Abstract 4902: Oxidized low-density lipoprotein is a potentially potent mediator of proteasome inhibitor resistance in multiple myeloma
Session PO.ET04.06 - Microenvironmental and Cell Nonautonomous Factors in Mediating Therapeutic Resistance
April 17, 2018, 1 - 5 p.m.; Section 40, Poster 18 

Odero-Marah_MMSIF_headshots_150x190_1.jpgValerie Odero-Marah, PhD
Associate Professor, Dept. of Biological Sci.
Clark Atlanta University
Atlanta, Georgia

Abstract 1096: STAT3 pathway regulates the cancer-bone microenvironment interactions mediated by Snail
Session PO.TB04.02 - Mechanisms Underlying Metastasis 2
April 16, 2018, 8 a.m. - noon; Section 4, Poster 13 

Parada_MMSIF_headshots_150x190_1.jpgHumberto Parada, PhD
Assistant Professor, Div. of Epidemiology and Biostatistics
San Diego State University
San Diego, California
Abstract 243: Genetic polymorphisms of diabetes-related genes, their interaction with diabetes status, and breast cancer incidence and mortality: The Long Island Breast Cancer Study Project
Session PO.EP01.03 - Genetic Contributions to Cancer Epidemiology 1: GWAS and Pathway and Candidate Gene Studies
April 15, 2018, 1 - 5 p.m.; Section 9, Poster 23 

Pertsemlidis_MMSIF_headshots_150x190_1.jpgAlexander Pertsemlidis, PhD
Associate Professor
UT Health Science Center at San Antonio
San Antonio, Texas
Abstract 4402: MiR-195 potentiates the efficacy of microtubule-targeting agents in non-small cell lung cancer
Session PO.MCB10.04 - MicroRNA Therapeutics
April 17, 2018, 1 - 5 p.m.; Section 19, Poster 3 

Sareddy_MMSIF_headshots_150x190_1.jpgGangadhara Reddy Sareddy, PhD
Assistant Professor, Dept. of OB-GYN
UT Health Science Center at San Antonio
San Antonio, Texas
Abstract 5875: Development of LIFR inhibitor EC359 as a novel therapeutic for ovarian cancer
Session PO.ET06.08 - Novel Targets and Therapeutics
April 18, 2018, 8 a.m. - noon; Section 39, Poster 22 

Torres-Ramos_MMSIF_headshots_150x190_1.jpgCarlos Torres Ramos, PhD
Associate Professor, Dept. of Physiology
Univ. of Puerto Rico Med. Sciences Campus
San Juan, Puerto Rico
Abstract 5041: Repair of azoxymethane-induced nuclear and mitochondrial DNA lesions in mouse liver
Session PO.TB11.03 - Carcinogenesis 3
April 18, 2018, 8 a.m. - noon; Section 2, Poster 1 

Trivedi_MMSIF_headshots_150x190_1.jpgMeghana V. Trivedi, PhD
Associate Professor, Pharmacy Practice and Translational Research
University of Houston
Houston, Texas
Abstract 1926: Npy1r as a prognostic marker and a novel drug target in estrogen receptor-positive breast cancer
Session PO.ET01.05 - New Targets 1
April 16, 2018, 8 a.m. - noon; Section 40, Poster 1 

Zabaleta_MMSIF_headshots_150x190_1.jpgJovanny Zabaleta, PhD
Associate Professor
Louisiana State University Health Sciences Center
New Orleans, Louisiana

Abstract 646: Immune checkpoints and inflammation in colon tumors from African Americans
Session PO.CL01.01 - Molecular Diagnostics 1: Cytogenetics, Clinical Molecular Genetics, and Clinical Imaging
April 15, 2018, 1 - 5 p.m.; Section 29, Poster 14